Convergence Investment Partners, LLC United Therapeutics Corp Transaction History

Convergence Investment Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$170.47 - $211.93 $294,060 - $365,579	-1,725 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$153.94 - $174.85 $265,546 - $301,616	1,725 New	1,725 $289,000
Q4 2020 Feb 05, 2021	SELL	$101.87 - $151.79 $975,405 - $1.45 Million	-9,575 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$99.9 - $121.13 $536,163 - $650,104	5,367 Added 127.54%	9,575 $967,000
Q2 2020 Jul 30, 2020	BUY	$92.74 - $125.82 $390,249 - $529,450	4,208 New	4,208 $509,000
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $684,855 - $869,442	-6,754 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $261,080 - $296,981	2,294 Added 51.43%	6,754 $864,000
Q2 2018 Aug 07, 2018	BUY	$101.14 - $118.31 $436,014 - $510,034	4,311 Added 2893.29%	4,460 $505,000
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $15,974 - $22,639	149 New	149 $17,000

723

60.9M

123K

104K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.